Authors:
Jostock, T
Mullberg, J
Ozbek, S
Atreya, R
Blinn, G
Voltz, N
Fischer, M
Neurath, MF
Rose-John, S
Citation: T. Jostock et al., Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses, EUR J BIOCH, 268(1), 2001, pp. 160-167
Authors:
Atreya, R
Mudter, J
Finotto, S
Mullberg, J
Jostock, T
Wirtz, S
Schutz, M
Bartsch, B
Holtmann, M
Becker, C
Strand, D
Czaja, J
Schlaak, JF
Lehr, HA
Autschbach, F
Schurmann, G
Nishimoto, N
Yoshizaki, K
Ito, H
Kishimoto, T
Galle, PR
Rose-John, S
Neurath, MF
Citation: R. Atreya et al., Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo, NAT MED, 6(5), 2000, pp. 583-588
Authors:
Hoischen, SH
Vollmer, P
Marz, P
Ozbek, S
Gotze, KS
Peschel, C
Jostock, T
Geib, T
Mullerg, J
Mechtersheimer, S
Fisher, M
Grotzinger, J
Galle, PR
Rose-John, S
Citation: Sh. Hoischen et al., Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells, EUR J BIOCH, 267(12), 2000, pp. 3604-3612
Authors:
Jostock, T
Blinn, G
Renne, C
Kallen, KJ
Rose-John, S
Mullberg, J
Citation: T. Jostock et al., Immunoadhesins of interleukin-6 and the IL-6 soluble IL-6R fusion protein hyper-IL-6, J IMMUNOL M, 223(2), 1999, pp. 171-183